EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Elbit Systems (ESLT)

Aerospace & Defense

Alembic Global Advisors

Alembic are reiterating their Overweight rating on shares of ESLT and are raising their target price by USD4 to US265. ESLT shares have been weak YTD, particularly recently, due, Alembic believe, to political factors. One manifestation of such factors is France’s recent decision to bar Israeli firms from the upcoming Eurosatory defense conference. Despite such issues, they do not believe the fundamentals support a weakening in ESLT shares and believe there is meaningful upside from here. As such, Alembic reiterate their Overweight rating. Their 15.5x terminal valuation is ~5% premium to the S&P 500 on FY1 EV/EBITDA and Alembic believe there is likely room for valuation upside should ESLT’s focus on margin rate and cash flow begin to bear fruit.

Edition: 188

- 14 June, 2024